Heart attack drug shows promise in reducing damage
Disease control
Completed
This study tested whether the drug henagliflozin, taken for 6 months after a heart attack, can reduce the size of heart muscle damage and improve heart function. 248 adults who had a specific type of heart attack (STEMI) and underwent a procedure to open blocked arteries particip…
Phase: PHASE4 • Sponsor: Qian geng • Aim: Disease control
Last updated May 01, 2026 16:00 UTC